Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera
Bioorganic & Medicinal Chemistry Letters · 2025
DOI: 10.1016/j.bmcl.2025.130286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2025. Verfasst von Grant B Frost und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Northwestern University, Evanston, IL 60208, United States of America. Hauptthemen laut MEDLINE: Drug Design, Enzyme Inhibitors, Telomerase. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Center, National Cancer Institute.
Abstract (Originalsprache)
Expression of telomerase reverse transcriptase (TERT) is a hallmark of cancer, maintaining telomere integrity to enable replicative immortality. However, TERT also serves multiple enzyme-dependent and -independent functions to support cancer growth and survival, including enhanced DNA damage response. Agents that inhibit TERT reverse transcriptase activity prevent telomere elongation but may fail to limit other TERT functions that mediate cancer therapy resistance. Thus, we applied structure-based design, modular synthesis, and biochemical assays towards developing a proteolysis targeting chimera (PROTAC) to drive proteasomal degradation of TERT in cancer cells. This yielded NU-PRO-1, a PROTAC linking the TERT active site-targeted covalent inhibitor NU-1 to the VHL E3-ligase ligand (S,R,S)-AHPC. Applied to cancer cells, NU-PRO-1 induced transient VHL- and proteasome-dependent TERT degradation. NU-PRO-1 did not induce DNA damage on its own but acted to further delay DNA repair after irradiation compared to NU-1. TERT-degrading PROTACs provide novel chemical probes of TERT's non-catalytic functions and may overcome the limitations of current telomerase inhibitors as cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Northwestern University, Evanston, IL 60208, United States of America.
- Ludwig Center for Metastasis Research and Department of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL 60637, United States of America.
- Ludwig Center for Metastasis Research and Department of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: skron@uchicago.edu.
- Department of Chemistry, Northwestern University, Evanston, IL 60208, United States of America; Robert. H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, United States of America. Electronic address: scheidt@nort…
Förderung
- NCI NIH HHS
- National Cancer Center
- National Cancer Institute
Zitieren
APA
Frost, G. B., Liu, Y., Kron, S. J., & Scheidt, K. A. (2025). Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2025.130286
Vancouver
Frost GB, Liu Y, Kron SJ, Scheidt KA. Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera. Bioorganic & Medicinal Chemistry Letters. 2025. doi:10.1016/j.bmcl.2025.130286
BibTeX
@article{Frost2025,
author = {Frost, Grant B and Liu, Yue and Kron, Stephen J and Scheidt, Karl A},
title = {Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2025},
doi = {10.1016/j.bmcl.2025.130286}
}
EUVIMED